Long Covid: a global health issue – a prospective, cohort study set in four continents.

Long Covid: a global health issue – a prospective, cohort study set in four continents.

Publication date: Oct 21, 2024

A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to characterise long-term COVID-19 sequelae in populations globally and compare the prevalence of reported symptoms in HICs and low-income and middle-income countries (LMICs). A prospective, observational study in 17 countries in Africa, Asia, Europe and South America, including adults with confirmed COVID-19 assessed at 2 to

Concepts Keywords
Africa Adult
America Africa
Covid Asia
Income Cohort Studies
Unknown Cohort study
COVID-19
COVID-19
Developed Countries
Developing Countries
Epidemiology
Europe
Female
Global Health
Global Health
Humans
Male
Middle Aged
Post-Acute COVID-19 Syndrome
Prevalence
Prospective Studies
Public Health
SARS-CoV-2
South America

Semantics

Type Source Name
disease MESH Long Covid
disease MESH COVID-19
disease MESH sequelae

Original Article

(Visited 2 times, 1 visits today)